Bioftalmik Information

Bioftalmik is a biotechnology company specialized in the development of diagnostic and prognostic systems for the field of ophthalmology. Bioftalmik offers quick, affordable, and routine-use solutions based on the specific molecular markers for each disease. For this, Bioftalmik has developed and validated new, non-invasive analysis (tears) and extraction (impression cytology) platforms. Bioftalmik is the first with marketable product developed from impression cytology designed to diagnose Limbal Deficiency (LIMBOKIT) Today, the diagnostic markers for pathologies with great prevalence and economic impact, such as Dry Eye Syndrome and Ocular Allergy Child, have been validated with results with accuracies over 95%. , Furthermore, The company has patents associated with the main ocular diseases and technological and business collaborations with the most prestigious clinics and ophthalmologists worldwide. Nowadays Bioftalmik is looking for local partners for distribution of LIMBOKIT all over the world (see Products)